3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Multiple Myeloma
2
Thrombocytopenia
1
Myelodysplastic Syndromes
1
Motor Activity
1
Leukemia
1
Hematologic Neoplasms
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cyclophosphamide
21
fludarabine phosphate
13
Cyclosporine
11
Antilymphocyte Serum
11
Peripheral Blood Stem Cell Transplantation
10
Methotrexate
10
Busulfan
10
Cytarabine
9
Filgrastim
8
Radiotherapy
7
Dexamethasone
7
Whole-Body Irradiation
6
Mycophenolic Acid
6
Methylprednisolone
6
Melphalan
6
Exercise
6
fludarabine
5
Vincristine
5
Daunorubicin
5
Cord Blood Stem Cell Transplantation
5
pegaspargase
4
Rituximab
4
Palliative Care
4
Mercaptopurine
4
Etoposide
4
Early Intervention, Educational
4
Blood Specimen Collection
4
Asparaginase
4
Alemtuzumab
4
Thioguanine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Leukemia
×
Platelet Transfusion
×
Clear all
NCT01615146
2015-09-02
OPTIMAL
Ottawa Hospital Research Institute
Phase NA
Terminated
9 enrolled